GlassScriptPhysician profile
Philip Jeffrey Cain
NPI 1932140076
$2,779.48
in general payments reported to CMS, 2019-2025
10 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,051 · 2021: $66.69 · 2022: $34.47 · 2023: $285 · 2024: $57.98 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,956.13 | 2019-2021 | |
| Stryker Corporation | $462.63 | 2023-2025 | Citrefix, Viaflow, 7 X 23mm Citrelock Implant |
| Organogenesis INC. | $151.84 | 2019-2025 | Simplimax |
| Ani Pharmaceuticals, INC. | $49.15 | 2025 | Purified Cortrophin Gel |
| Nevro Corp. | $38.44 | 2023-2024 | Senza |
| Nabriva Therapeutics, Plc | $34.47 | 2022 | |
| Medtronic, INC. | $27.03 | 2025 | Minimed 780g |
| Heron Therapeutics, INC. | $24.98 | 2021 | |
| Abbott Laboratories | $18.03 | 2023 | Octrode |
| Orthofix Medical, INC. | $16.78 | 2025 | Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.